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Introduction On orbit, ophthalmic anesthetics are used for tonometry and off-nominal 
corneal examinations. Proparacaine has been flown traditionally. However, the 
manufacturers recently changed its storage requirements from room temperature storage 
to refrigerated storage to preserve stability and prolong the shelf-life. Since refrigeration 
on orbit is not readily available and there were stability concerns about flying 
proparacaine unrefrigerated, tetracaine was selected as an alternative ophthalmic 
anesthetic in 2013. We will discuss the challenges encountered flying and using these 
anesthetics on the International Space Station. 
 
Methods The NASA Johnson Space Center Pharmacy Team researched the stability of 
the proparacaine under room temperature conditions. A comparison between 
proparacaine and tetracaine was provided to the operational flight surgeons, who 
approved tetracaine for use in microgravity.  
 
Results Tetracaine began flying in crewmembers’ individual medical accessory kits 
before it was permanently incorporated into the standard medical kit. Tetracaine was used 
on 5 crewmembers as a topical anesthetic for tonometry testing during this timeframe. 
Two of the 5 experienced corneal flushing and scleral injection which interfered with 
interpretation of on-orbit surveillance testing results. Corneal flushing and scleral 
injection have not been noted with use of proparacaine. These findings required a switch 
back to proparacaine, necessitating a new process to be developed to supply the 
medication refrigerated. 
  
Discussion Storage requirements of medications in spaceflight is an important factor to 
consider. In the absence of stability data, performance of the medication and/or the 
diagnostic testing may be affected. Selection of medications for future exploration 
missions will need to consider storage. Stability studies will need to be conducted to 
ascertain the safety and effectiveness of medications for medications if the necessary 
storage conditions will not be engineered into the spacecraft.  
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